Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds
Chronic pancreatitis (CP) is a precancerous illness linked to pancreatic ductal adenocarcinoma (PDAC), although the evolutionary mechanism is uncertain. CP is distinguished by severe fibrosis caused by the activation of pancreatic stellate cells (PSCs). The current clinical therapeutic protocol for...
Main Authors: | Yang Wu, Chun Zhang, Mei Guo, Weikang Hu, Yangling Qiu, Mengran Li, Dong Xu, Pengfei Wu, Jing Sun, Run Shi, Zili Zhang, Kuirong Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1042651/full |
Similar Items
-
Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis
by: Fanyi Kong, et al.
Published: (2024-01-01) -
Pancreatic Stellate Cells and the Targeted Therapeutic Strategies in Chronic Pancreatitis
by: Man Chang, et al.
Published: (2023-07-01) -
Progress of Pancreatic Stellate Cells in Research of Pancreatic Disease Model
by: WEI Xun, et al.
Published: (2022-04-01) -
Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
by: Can Huang, et al.
Published: (2021-05-01) -
Interstitial lung disease: Does it matter what we call you, or what you look like, or how you behave?
by: R van Zyl-Smit, et al.
Published: (2023-08-01)